Orphapacket:
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  Label: Acute myeloid leukemia and myelodysplastic syndromes related to alkylating
    agent
  ORPHAcode: '102379'
  ORPHApacketId: '102379'
  PURL: http://www.orpha.net/ORDO/Orphanet_102379
  Parents:
  - Parent:
    - Label: Therapy related acute myeloid leukemia and myelodysplastic syndrome
      ORPHAcode: '86846'
  Synonyms:
  - Synonym: AML and myelodysplastic syndromes related to alkylating agent
  TextSection:
    Contents: A subgroup of therapy-related myeloid neoplasms (t-MN) associated with
      a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic
      agents like cyclophosphamid platins melphalan and others. The neoplastic cells
      typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q)
      and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage
      dysplasia and cytopenias 5-10 years after exposure with symptoms related to
      the degree of bone marrow failure and the corresponding cytopenia (fatigue bleeding
      and bruising recurrent infections bone pain).
    TextSectionType: Definition
  copyright: Orphanet (c) 2025
  creationDate: '2025-06-26 11:48:15'
  version: 1.3.42 / 4.1.8 [2025-03-03]
